Finance Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics by CoinNews January 8, 2024 by CoinNews January 8, 2024 Investing in cutting-edge companies is a bit riskier than investing in tried-and-tested players, but breaking… Read more 0 FacebookTwitterPinterestEmail
Finance Omega Therapeutics stock more than doubles on Novo Nordisk obesity drug research pact by CoinNews January 4, 2024 by CoinNews January 4, 2024 Novo Nordisk has entered research collaboration agreements with Omega Therapeutics Inc. and Cellarity Inc. on… Read more 0 FacebookTwitterPinterestEmail
Finance Structure Therapeutics Stock Just Crashed. Here’s Why It Could Be Worth Buying Now by CoinNews December 25, 2023 by CoinNews December 25, 2023 Before biotech companies have sales to report to investors, their share prices often live and… Read more 0 FacebookTwitterPinterestEmail
Finance Is CRISPR Therapeutics the Best Gene-Editing Stock? by CoinNews November 22, 2023 by CoinNews November 22, 2023 A striking analogy can be drawn between the development of monoclonal antibodies and the emergence… Read more 0 FacebookTwitterPinterestEmail
Finance Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire? by CoinNews November 19, 2023 by CoinNews November 19, 2023 All eyes have been on CRISPR Therapeutics (CRSP 14.64%) in recent times because the biotech… Read more 0 FacebookTwitterPinterestEmail
Finance Tempest Therapeutics’ stock jumps nearly 4,000% as liver-cancer treatment shows promise by CoinNews October 11, 2023 by CoinNews October 11, 2023 Shares of Tempest Therapeutics Inc. TPST, +3972.53% soared nearly 4,000% on Wednesday after the company… Read more 0 FacebookTwitterPinterestEmail
Finance More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics by CoinNews September 12, 2023 by CoinNews September 12, 2023 Gene editing is a relatively new technology that allows scientists to modify an organism’s DNA.… Read more 0 FacebookTwitterPinterestEmail
Finance After Blasting Off 881% in 1 Year, Is Viking Therapeutics Still a Good Buy? by CoinNews June 20, 2023 by CoinNews June 20, 2023 Viking Therapeutics (NASDAQ: VKTX) is up 881% in the last 12 months thanks to its… Read more 0 FacebookTwitterPinterestEmail